JREG:F:F-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity Fund (EUR)

ETF | Others |

Last Closing

USD 47.845

Change

-0.72 (-1.47)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.22 (-0.80%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.42 (-0.82%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

-9.16 (-1.53%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.10 (-0.63%)

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

-1.74 (-1.62%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-1.69 (-1.57%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.70 (-1.56%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

+0.08 (+1.05%)

USD 40.89B
0ZC:F Zscaler Inc

-8.14 (-4.11%)

USD 37.92B

ETFs Containing JREG:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.42% 84% B 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.42% 83% B 73% C
Trailing 12 Months  
Capital Gain 29.66% 82% B 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.66% 80% B- 70% C-
Trailing 5 Years  
Capital Gain 93.98% 93% A 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 93.98% 93% A 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 15.81% 90% A- 78% C+
Dividend Return 15.81% 88% B+ 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.16% 46% F 80% B-
Risk Adjusted Return 111.67% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.